Isto Technologies
St Louis · Founded 1997
About Isto Technologies
ISTO Technologies, Inc., an orthobiologics company, develops biologic products to regenerate and restore function to damaged cartilage and bone. It offers InQu, a resorbable bone graft extender and substitute; NuQu, a cell-based injectable therapy for disc regeneration; and DeNovo ET, an engineered cartilage implant for the repair and regeneration of knee cartilage. The company provides its products through distributors. ISTO Technologies, Inc. was founded in 1997 and is based in St. Louis, Missouri.
Company Facts
- Founded: 1997
- Legal name: ISTO TECHNOLOGIES, INC.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $33.9M
- Funding stage: M&A
- Last round: Grant (Jul 2015)
- Website: istotech.com
- Phone: +1 314-995-6049
Canonical: https://fsome.com/organization/isto-technologies-8267528 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.